Follow

New preprint online today!

Patient Benefit and Risk in Anticancer Drug Development: A Systematic Review of the Ixabepilone Trial Portfolio by Carlisle et al, medRxiv, 2019.

:doi: doi.org/10.1101/19003467

Sign in to participate in the conversation
Scholar Social

The social network of the future: No ads, no corporate surveillance, ethical design, and decentralization! Own your data with Mastodon!